The Political Economy of Pharmaceutical Underdevelopmen

医药不发达的政治经济学

• 批准号: 2888806
• 金额: --
• 依托单位: King's College London
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-2888806
• 关键词: Political; Economy; Pharmaceutical; Underdevelopmen

Despite adopting macroeconomic reforms designed toimprove the diffusion of technologies and adoption of newideas, technological innovation has remained limited inSouth Africa. Consider innovation in the pharmaceutical andlife sciences sectors. Hailed as the largest manufacturer inthe continent, South Africa has long had the ambition to beindependent in its pharmaceutical production. Yet itcontinues to channel funds towards the Global North,importing between 70-90% of essential medicines. In thisresearch project, I will look to uncover why and how this is,examining how economic policies such as strengthenedintellectual property laws, fiscal restraint, and tradeliberalisation have shaped the development of thepharmaceutical sector within South Africa.The project will adopt a mixed methods approach deliveredthrough two phases. I will first conduct a historical study ofSouth Africa's post-apartheid transition, focussing on itseconomic reforms, before conducting a set of detailed casestudies. Each focussing on a specific disease area, the casestudies will explore how the economic reforms highlightedin the first phase have conditioned scientific attempts todevelop essential medicines; policy options; and the abilityof local industry to respond. In this way, the project willdevelop a causal account of how macroeconomic policyshapes pharmaceutical underdevelopment in the GlobalSouth.

尽管采取了旨在促进技术传播和新思想采用的宏观经济改革，但南非的技术创新仍然有限。考虑制药和生命科学领域的创新。南非被誉为非洲大陆最大的制造商，长期以来一直有独立药品生产的雄心。然而，它继续向北半球国家输送资金，进口 70-90% 的基本药物。在这个研究项目中，我将寻求揭示其原因和方式，研究加强知识产权法、财政限制和贸易自由化等经济政策如何影响南非制药业的发展。该项目将采用分两个阶段实施的混合方法。我将首先对南非后种族隔离转型进行历史研究，重点关注其经济改革，然后进行一系列详细的案例研究。每个案例研究都侧重于特定的疾病领域，将探讨第一阶段强调的经济改革如何影响开发基本药物的科学尝试；政策选择；以及当地工业的应对能力。通过这种方式，该项目将对宏观经济政策如何影响南半球制药业的发展进行因果解释。